摘要
目的:进一步了解大肠癌患者的异常免疫状态,探讨sTNFRⅠ检测的临床意义。方法:用双单抗夹心酶联免疫吸附法检测sTNFRⅠ含量。结果:大肠癌C期、D期病人的血sTNFRⅠ浓度显著高于正常对照,为130190±137920u/L、207400±137390u/L比51640±26670u/L。sTNFRⅠ升高程度及异常发生率与肿瘤分期、血CEA的异常率有关,而与肿瘤的分化程度无关。结论:sTNFRⅠ的检测对协助大肠癌的早期诊断、病人复发随访及预后判断具有实用价值。
Purpose: To further understand the abnormal immune status of patients with colorectal cancer and to investigate the clinical significance of detection for sTNFRⅠ concentration. Method: Two monoclonal antibodies sandwich enzyme-linked immunosorbent assay was used for determining sTNFRⅠ contents. Results: The results showed that the mean±SD concentration of sTNFRⅠ was significantly higher in the cancer patients at stage C and stage D than in the healthy controls: 130190±137920 U/L and 207400±137390 U/L versus 51640±26670 U/L. The incidence and the extent of the increase of sTNFRⅠ correlated with the staging of disease and the incidence of elevated serum CEA, not with the differentiation of tumor. Conclusions: The determination of serum levels of sTNFRⅠ may serve as a diagnostic aid in the early detection, follow-up and prognosis of colorectal cancer.
出处
《癌症》
SCIE
CAS
CSCD
北大核心
1998年第2期93-95,共3页
Chinese Journal of Cancer
基金
广东省自然科学基金
关键词
大肠肿瘤
STNFR-I
ELISA
Soluble tumor necrosis factor receptor Ⅰ (sTNFRⅠ) ELISA Colorectal cancer